NEW YORK (GenomeWeb News) – Beckman Coulter said today that it has licensed certain rights to hepatitis C virus testing from Siemens Healthcare Diagnostics.
Beckman said that under the agreement it received rights to develop, manufacture, and sell a quantitative viral load HCV blood test for use on a molecular diagnostics instrument. The firm is developing a next-generation molecular diagnostics platform, called the UniCel DxN, which it plans to launch in 2010.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.